Latin American Patient Academy (LAPA) held its second session in Lima to continue to build the advocacy capacity of patients and patient organizations in Latin America

The Latin American Patient Academy (LAPA) held its second session during the 3rdAnnual Latin American Summit for the Promotion of Biological and Biosimilar Policies of GAfPAfrom September 6-7 in Lima, Peru.

In line with the goals of the Summit,the objective of LAPA’s second session was to highlight the important role of patients and patient organizations in the Health Technology Assessment process.28 leaders from Latin American patient organizations received training in the evaluation of health technologies.

The meeting was guided and executed by representatives from the pharmaceutical industry in Latin America.

LAPA, an advocacy capacity building program, is a joint program of the Global Alliance for Patient Access (GAfPA), the International Association of Patient Organizations (IAPO), and Alianza Latina, with academic support from the Department of Adult Virtual Education of the Catholic University of Peru, and financial support from 13 FIFARMA member pharmaceutical companies. 

 

Autor: María Alejandra De Guzman –FIFARMA Communications Manager